HUM vs KYMR · P/E 39, rev $129.66B vs rev $47.1M
Humana Inc (HUM) versus Kymera Therapeutics Inc (KYMR) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported KYMR revenue for 2024-12-31 was $47.1M. Net income was -$223.9M. Revenue was down 40.1% from 2023-12-31 to 2024-12-31. KYMR currently screens at market cap $7.39B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. KYMR currently screens at market cap $7.39B.
Not investment advice. Open the HUM and KYMR stock pages for the full models.
Not investment advice.